Aug 13, 2026 earnings call — Direct patient services growth and financing progress
Reported quarterly revenue of approximately 8.4 million, up 19.2% year over year, driven by growth in direct patient services.
Revenue $0.0B (est $0.0B) · EPS $-0.07 (est $-0.02)
Key quotes
"Those results were driven by continued growth in our direct patient services segment."
"1 of the most encouraging trends we continue to see is improving utilization across our network."
"In addition, this new company has invested $2 million of subordinated financing after quarter end which reflects our continued confidence in the long term prospects of the company and provides additional financial flexibility as we move forward."
Analyst Q&A 3
driving procedure volume internationally
Q (Marla Marin · Zacks): The analyst asked if the company can control and increase procedure volumes at international centers like they did in Rhode Island with Brown Healthcare and new centers.
A: No management answer is included in the provided transcript for this exchange.
loan terms and sale requirement
Q (Tony Kamin · Eastwood Partners): The analyst asked how the company can pursue long-term value for shareholders while the loan amendment appears to require pursuing a sale of ASHS or assets.
A: The company said the credit agreement with Fifth Third gives them time by extending loan maturity to 06/30/2027. They stated the company owes Fifth Third about 15.5 million by the end of June next year, which will be down to about 13.3 million, and that they generated 4.4 million of cash in the first 6 months and ended the quarter with 6.8 million of cash plus a 2 million deposit. They said a sale of the company is not necessarily required and they are pursuing any and all options to refinance the indebtedness.
"Well, think it is fair to say we are any and all options it is very clear that we have been given a 12-month extension of maturity plus over 12 month extension of the maturity of our loans, to 06/30/2027." — Raymond C. Stachowiak (CHAIR)
$909k accounts receivable charge
Q (Anthony Marchese · Private Investor): The analyst asked what caused the nearly $900 thousand accounts receivable charge, whether it involved one or multiple accounts, and if it could happen again.
A: They said the receivables through 05/31/2025 related to several payers and they expect a $909 thousand reduction in the viability of those receivables. They clarified that, for the most part, the unpaid receivables come from insurance carriers and said they are not proud of the charge.
"For the most part, it comes from the insurance carriers." — Raymond C. Stachowiak (CHAIR)